Last reviewed · How we verify
NCT06041100
What Are the Effects of a Bilateral Hip Exoskeleton During Daily Use by 65+ Adults?
NA trial testing Exoskeleton in Pre-frail Senior Adults in 16 participants. Completed in 31 January 2024.
30 January 2024
Quick facts
| Lead sponsor | Aalborg University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 16 |
| Start date | 6 September 2023 |
| Primary completion | 30 January 2024 |
| Estimated completion | 31 January 2024 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Exoskeleton
Conditions studied
- Pre-frail Senior Adults — all drugs for Pre-frail Senior Adults →
Sponsor
Aalborg University
Who can join
Adults 65 to 85, any sex, with Pre-frail Senior Adults. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Despite the huge popularity exoskeletons have gained in the past years and the benefits that they have shown to provide to users, there are still many aspects of wearing an exoskeleton that have yet to be determined. Therefore, the main objective of this study is to evaluate the feasibility using the acceptability of incorporating a passive assistive bilateral exoskeleton into the daily routine of pre-frail adults for a duration of 12-weeks. The second aim of the study is to determine whether this effect can be sustained even after a period of 6-weeks following the cessation of usage.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06041100
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exoskeleton
Trials testing the same drug.
- NCT07323147 — Clinical Efficacy of Exoskeleton Robot-Assisted Rehabilitation on Lower Limb Functional Recovery in Elderly Patients Wit · NA · enrolling by invitation
- NCT04978467 — SPiRE Maestro Hand Exoskeleton for Rehabilitation Post Stroke · NA · withdrawn
- NCT06028529 — Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease · NA · recruiting
- NCT06222398 — Exoskeleton Use With In Home Functional Activities · terminated
- NCT05473208 — Lumbar Assistive Exoskeletons in Caregiving · NA · unknown
Other Aalborg University trials
Trials by the same sponsor.
- NCT07580989 — Network Effects of Left M1 rTMS: A TMS-EEG Study · NA · recruiting
- NCT07395882 — A New Model to Induce Itch and Inflammation · NA · not yet recruiting
- NCT07395869 — Off-set Analgesia Induced by Cold Temperature · NA · not yet recruiting
- NCT07266103 — Mechanistic Study of Personalized rTMS in Chronic Pain · NA · not yet recruiting
- NCT07373392 — Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals Wi · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06041100 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aalborg University
- Last refreshed: 1 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06041100.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing